The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK blue chips end higher as telecoms group BT surges on stake buy

Thu, 10th Jun 2021 08:53

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* AstraZeneca, pharma stocks lead gains

* Investors shrug off spike in U.S. inflation

* BT tops FTSE 100 after Altice takes 12% stake

* FTSE 100 up 0.1%, FTSE 250 down 0.7%
(Updates to close)

By Sagarika Jaisinghani and Sruthi Shankar

June 10 (Reuters) - Britain's blue-chip index closed
slightly higher on Thursday, aided by gains in telecoms group BT
and pharma majors, while doubts over the UK's reopening plans
later this month hurt the domestically focused mid-cap index.

Shares in BT Group jumped 6.6% to hit their highest
since January 2020 after telecoms billionaire Patrick Drahi's
Altice Group bought a 12.1% stake worth about 2.2
billion pounds ($3.1 billion), making it the largest
shareholder.

"Altice is an established name in the telecoms space and the
purchase of a 12% holding in BT is a significant move," said AJ
Bell investment director Russ Mould.

"It has been said for years that UK assets are cheap and
2021 is proving to be the year when investors finally put their
money where their mouth is."

The export-heavy FTSE 100 ended the day up 0.1%,
also boosted by drugmakers AstraZeneca and
GlaxoSmithKline.

Global stocks remained buoyant, with Wall Street's S&P 500
reaching a record high as investors took to the view that
a spike in May consumer prices was probably not enough to drive
an early policy tightening by the Federal Reserve.

The European Central Bank also pledged to keep monetary
policy loose despite lifting its growth and inflation
projections for the euro zone.

Stocks more exposed to the domestic economy took a hit, with
the UK's mid-cap index falling 0.7% in its third session
of losses amid doubts over a full reopening of the country on
June 21 as coronavirus cases pick-up again.

Meanwhile, Britain and the European Union failed to agree on
solutions to post-Brexit trade problems in Northern Ireland this
week, with the two sides exchanging threats, including
imposition of tariffs and quotas.

Among other stocks, facilities management provider Mitie
jumped 5.9% as it predicted its full-year profit would
beat current market estimates.

Online trading platform CMC Markets rose 1.7% as it
said annual profits had more than doubled.
(Reporting by Sagarika Jaisinghani in Bengaluru; editing by
Uttaresh.V and Mark Heinrich)

More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.